BrainsWay Ltd. (TLV:BWAY)
4,350.00
-162.00 (-3.59%)
Aug 24, 2026, 12:27 PM IDT
BrainsWay Revenue
BrainsWay had revenue of $17.11M USD in the quarter ending June 30, 2026, with 35.43% growth. This brings the company's revenue in the last twelve months to $60.70M, up 31.71% year-over-year. In the year 2025, BrainsWay had annual revenue of $52.23M with 27.33% growth.
Revenue (ttm)
$60.70M
Revenue Growth
+31.71%
P/S Ratio
10.00
Revenue / Employee
$470.50K
Employees
129
Market Cap
1.81B ILS
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.23M | 11.21M | 27.33% |
| Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
| Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
| Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
| Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
| Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
| Dec 31, 2019 | 23.10M | 6.70M | 40.89% |
| Dec 31, 2018 | 16.40M | 5.25M | 47.12% |
| Dec 31, 2017 | 11.15M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 885.35M |
| Kamada | 571.54M |
| SofWave Medical | 310.85M |
| Bait Bakfar | 111.90M |
BrainsWay News
- 6 days ago - Brainsway (BWAY) Upgraded to Buy: Here's Why - Nasdaq
- 7 days ago - Brainsway reports Q2 EPS 7c, consensus 7c - TheFly
- 7 days ago - Brainsway raises FY26 revenue view to $68M-$70M from $66M-$68M - TheFly
- 7 days ago - Brainsway price target raised to $18.80 from $18 at Ladenburg - TheFly
- 11 days ago - Brainsway Q2 Earnings Call Highlights - MarketBeat
- 11 days ago - BrainsWay Earnings Call Transcript: Q2 2026 - Transcripts
- 11 days ago - BrainsWay Earnings release: Q2 2026 - Filings
- 11 days ago - BrainsWay Ltd (BWAY) Shares Surge 11.0% -- What GF Score of 58 Tells Investors - GuruFocus